Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.67 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | PPARD | Q03181 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL872327 | 1.00 | TSHR (0.67) | TSHRCYP3A4ALDH1A1TP53TDP1 | |
| SCHEMBL6273213 | 0.97 | TSHR (0.62) | TSHRCYP3A4ALDH1A1TP53TDP1 | |
| SCHEMBL13963394 | 0.93 | TSHR (0.65) | TSHRCYP3A4ALDH1A1TP53TDP1 | |
| SCHEMBL15293621 | 0.93 | TSHR (0.65) | TSHRCYP3A4ALDH1A1TP53TDP1 | |
| Ammonia Solution, Strong SCHEMBL28386014 | 0.90 | TSHR (0.62) | TSHRCYP3A4ALDH1A1TP53TDP1 | |
| SCHEMBL117529 | 0.90 | TSHR (0.68) | TSHRCYP3A4ALDH1A1TP53TDP1 | |
| SCHEMBL15283502 | 0.89 | TSHR (0.88) | TSHRCYP3A4THRBHPGDSMN1; SMN2 | |
| SCHEMBL7556520 | 0.86 | CYP3A4 (0.76) | TSHRCYP3A4HPGDSMN1; SMN2 | |
| SCHEMBL5600582 | 0.85 | CYP3A4 (0.61) | TSHRCYP3A4ALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL5602837 | 0.85 | CYP3A4 (0.61) | TSHRCYP3A4ALDH1A1HPGDSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8785520-B2 | Process for production of polylactic acid resin composition | KAO CORPORATION (JP) | 2014-07-22 | — | — | US | claimed |
| EP-2653499-A1 | POLYLACTIC ACID RESIN COMPOSITION | Kao Corporation (JP) | 2013-10-23 | — | — | EP | claimed |
| US-20130261214-A1 | POLYLACTIC ACID RESIN COMPOSITION | KAO CORPORATION (JP) | 2013-10-03 | — | — | US | claimed |
| US-20120296017-A1 | PROCESS FOR PRODUCTION OF POLYLACTIC ACID RESIN COMPOSITION | KAO CORPORATION (JP) | 2012-11-22 | — | — | US | claimed |
| US-20050123578-A1 | Method of treating skin with a composition comprising a phosphoric triester and a skin activating component | KAO CORPORATION (JP) | 2005-06-09 | — | — | US | claimed |
| US-6451327-B1 | GRANULATED ANIONIC, NONIONIC, AND/OR AMPHOTERIC SURFACTANTS AND BINDER IN NONAQUEOUS BASE; SENSISTIVITY; MASSAGED FEEL | KAO CORPORATION (JP) | 2002-09-17 | — | — | US | claimed |
| US-5972877-A | MIXTURE OF A POLYOL ETHER, ANIONIC SURFACTANT AND THICKENER | KAO CORPORATION (JP) | 1999-10-26 | — | — | US | claimed |
| US-4140647-A | ORGANIC ETHER PHOSPHATE, INORGANIC BASE, ANIONIC AND NONIONIC SURFACTANTS, WATER | KAO SOAP CO., LTD. (JP) | 1979-02-20 | — | — | US | claimed |
| JP-10017581-A | — | — | None | — | — | JP | disclosed |
| US-11267232-B2 | Decorative film, method for producing decorative film, and method for producing three-dimensional molded product provided with decorative film | AGC Inc. (JP) | 2022-03-08 | — | — | US | disclosed |
| EP-3656545-B1 | SOLUBLE MATERIAL FOR THREE-DIMENSIONAL MOLDING | KAO CORP (JP) | 2021-06-23 | — | — | EP | disclosed |
| US-20210101376-A1 | DECORATIVE FILM, METHOD FOR PRODUCING DECORATIVE FILM, AND METHOD FOR PRODUCING THREE-DIMENSIONAL MOLDED PRODUCT PROVIDED WITH DECORATIVE FILM | AGC Inc. (JP) | 2021-04-08 | — | — | US | disclosed |
| US-10954378-B2 | Soluble material for three-dimensional molding | KAO CORPORATION (JP) | 2021-03-23 | — | — | US | disclosed |
| US-10738142-B2 | Soluble material for three-dimensional molding | KAO CORPORATION (JP) | 2020-08-11 | — | — | US | disclosed |
| US-20020187166-A1 | COSMETIC COMPOSITION COMPRISING A PHOSPHORIC TRIESTER AND A SKIN ACTIVATING COMPONENT | KAO CORPORATION (JP) | 2002-12-12 | — | — | US | disclosed |
| US-6451327-B1 | GRANULATED ANIONIC, NONIONIC, AND/OR AMPHOTERIC SURFACTANTS AND BINDER IN NONAQUEOUS BASE; SENSISTIVITY; MASSAGED FEEL | KAO CORPORATION (JP) | 2002-09-17 | — | — | US | disclosed |
| EP-1016403-A2 | Skin cleansing composition | Kao Corporation (JP) | 2000-07-05 | — | — | EP | disclosed |
| EP-0965328-A1 | COSMETIC | Kao Corporation (JP) | 1999-12-22 | — | — | EP | disclosed |
| US-5972877-A | MIXTURE OF A POLYOL ETHER, ANIONIC SURFACTANT AND THICKENER | KAO CORPORATION (JP) | 1999-10-26 | — | — | US | disclosed |
| JP-H1017581-A | PRODUCTION OF PHOSPHORIC TRIESTER | KAO CORP | 1998-01-20 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050123578-A1 | Method of treating skin with a composition comprising a phosphoric triester and a skin activating component | CUTA, PIM1, PIM2 | TSHR 1920/4885CYP3A4 3561/4885ALDH1A1 3649/4885 |
| US-20020187166-A1 | COSMETIC COMPOSITION COMPRISING A PHOSPHORIC TRIESTER AND A SKIN ACTIVATING COMPONENT | CUTA, PIM1, PIM2 | TSHR 2181/4885CYP3A4 3813/4885ALDH1A1 3338/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.